×

Pfizer CEO: Ibrance drug well received by physicians

11:16 AM ET Mon, 1 June 2015

Pfizer CEO Ian Read, discusses the PALOMA-3 trial for its oncology treatment Ibrance to treat breast cancer, drug pricing and competition in the pharmaceutical industry.